Cardio IVD Solutions

The Unique Chest Pain Analyzer

Chest pain is a common symptom that can be caused by a variety of factors, including heart problems, lung issues, gastrointestinal problems, musculoskeletal problems, and even anxiety and stress. It may present as a sharp, stabbing pain, a dull ache, burning, tightness, pressure or a squeezing sensation. It can occur suddenly or gradually and may be accompanied by other symptoms like shortness of breath, sweating, nausea or vomiting.

• Heart-related chest pain is typically caused by a lack of blood flow to the heart, usually due to coronary artery disease. Other heart-related causes include inflammation of the heart muscle or lining of the heart, a heart attack, or aortic aneurysm.
• Lung-related chest pain can be caused by infections, such as pneumonia, asthma, and chronic obstructive pulmonary disease (COPD), or a collapsed lung.
• Gastrointestinal problems can manifest as chest pain, such as gastroesophageal reflux disease (GERD), esophagus inflammation, or gallbladder disease.
• Musculoskeletal problems, such as costochondritis, can cause chest pain.

If you experience chest pain or chest discomfort, especially if accompanied by other symptoms like shortness of breath, or if it doesn't go away with rest or the use of nitrate medications like nitroglycerin, it is best to seek medical attention immediately. Your healthcare provider may perform a physical examination and diagnostic tests like blood tests, electrocardiogram (ECG), chest X-ray, CT scan, or echocardiogram to determine the cause of your chest pain and provide appropriate treatment.

results:

• Qualitative visible results
• Optional readable version with Quantitative results (customized)

H-FABP the very fast and EFFICIENCY biomarker

H-FABP, which stands for heart-type fatty acid binding protein, is a biomarker used in the diagnosis and prognosis of acute myocardial infarction (AMI), also known as a heart attack. Here are some of the advantages of using H-FABP:

• Early detection: H-FABP is detectable in blood within 30 minutes of an acute myocardial infarction, making it useful in early diagnosis.
• High sensitivity: H-FABP has been found to be more sensitive than other cardiac biomarkers such as troponin in the early diagnosis of AMI.
• Prognostic value: Elevated levels of H-FABP in the blood of patients with AMI are associated with an increased risk of complications and mortality, making it a useful predictor of outcomes.
• Cost-effective: H-FABP is a relatively economical biomarker compared to other cardiac biomarkers such as troponin, making it an attractive option for resource-limited settings.
•  Non-invasive: Blood samples are used to detect H-FABP levels, which is a non-invasive and less painful option for patients compared to other tests such as angiograms.

Overall, the advantages of H-FABP as a biomarker in the diagnosis and prognosis of AMI make it a valuable tool in the clinical setting.

results:

• Qualitative visible results
• FIA version for IVD reader with quantitative result and interface to networks and nprinters 

D-Dimer thrombosis analyzer

D-DIMER is a quick and relatively inexpensive laboratory test used to rule out blood clots in patients. Some of the main advantages of the D-DIMER test are:

• Quick results: The D-DIMER test can produce results in as little as 10 minutes. This makes it a valuable tool for emergency situations where time is of the essence.
• Non-invasive: The D-DIMER test is a simple blood test that does not require any invasive procedures. This makes it an excellent option for patients who cannot undergo procedures like CT scans or ultrasounds.
• Cost-effective: The D-DIMER test is relatively inexpensive compared to other diagnostic tests for blood clots.
• Safe: The D-DIMER test is a safe diagnostic tool that does not expose patients to radiation or other harmful substances.
• High sensitivity: The D-DIMER test is highly sensitive, meaning that it can detect even small amounts of blood clots. This makes it an effective tool for ruling out blood clots in patients.

Helps avoid unnecessary treatments and hospitalizations: Because the D-DIMER test is highly sensitive, it can help prevent unnecessary treatments and hospitalizations for patients who do not have blood clots. This can save patients time and money and reduce the risk of complications.

results:

• Qualitative visible results
• FIA version for IVD reader with quantitative result and interface to networks and nprinters 

Heart Failure NT-PRO BNP

 Accurate diagnosis of heart failure: NT-proBNP is a reliable biomarker for detecting heart failure. It can accurately assess the severity and prognosis of the condition.

• Early detection of heart failure: The early detection of heart failure using NT-proBNP allows for timely interventions that can improve the patient's outcome.
• Monitoring of heart failure: NT-proBNP levels can be used to monitor the progression of heart failure and the effectiveness of treatments.
• Risk stratification: NT-proBNP can help identify patients at higher risk of developing heart failure or experiencing adverse outcomes.
• No interference from co-existing conditions: NT-proBNP is not affected by co-existing conditions such as renal or liver dysfunction, making it a more reliable marker for detecting heart failure.
• Predictive of cardiovascular events: High levels of NT-proBNP are associated with increased risk of cardiovascular events such as heart attack or stroke, making it a valuable tool for predicting such events.

Easy to measure: NT-proBNP can be easily measured in a blood sample, making it a non-invasive and cost-effective method for diagnosing and monitoring heart failure.

results:

• Qualitative visible results
• FIA version for IVD reader with quantitative result and interface to networks and nprinters 

COVID-19 +4 Combo Rapid Test

The Biopanda COVID-19 / Influenza A+B / RSV / Adenovirus / M. pneumoniae
Antigen Combo lateral flow immuno-chromatographic assay is a qualitative
test for the detection of SARS-CoV-2 Nucleocapsid protein, Influenza A+B,
Respiratory Syncytial Virus (RSV), Adenovirus, and M. pneumoniae antigens
present in nasopharyngeal swab samples. It is intended for use as a tool to
assist in the diagnosis of SARS-CoV-2, Influenza A+B, RSV, Adenovirus, and M.
pneumoniae, in conjunction with other tests.

• Very easy to use
• Nasopharyngeal Swab to the samples Covid-19+ (5 x samples)
• Result can be read visually in 15 minutes
• Cost effective method to identifying multi viruses infection

results:

• Qualitative visible results